Biolase Stock Price, News & Analysis

BIOLASE, Inc. (BIOLQ) was a medical device company that specialized in developing, manufacturing, and selling dental laser systems. The company designed laser technology for dental practitioners including dentists, periodontists, endodontists, pediatric dentists, and oral surgeons. BIOLASE enabled these professionals to perform minimally invasive dental procedures across cosmetic, restorative, and complex surgical applications.

Company Background

Founded in 1984 and headquartered in Foothill Ranch, California, the company operated under the name BIOLASE Technology, Inc. before rebranding to BIOLASE, Inc. in 2012. The company previously traded on the NASDAQ exchange under the ticker symbol BIOL before transitioning to OTC markets as BIOLQ.

Core Products and Technology

BIOLASE's primary product lines included two categories of dental laser systems:

• Waterlase Systems: All-tissue laser platforms capable of cutting both soft and hard dental tissue, allowing for procedures that traditionally required drills and other mechanical instruments
• Diode Laser Systems: Soft-tissue lasers designed for soft tissue procedures, pain therapy applications, and cosmetic treatments including teeth whitening

Beyond the laser hardware, BIOLASE manufactured and sold consumable products and accessories for its laser systems, including flexible fibers, hand pieces, and teeth whitening gel kits. This consumables business provided recurring revenue alongside equipment sales.

Market Position and Industry Context

BIOLASE operated in the dental equipment and supplies industry, specifically within the niche segment of laser dentistry. The company positioned its products as alternatives to traditional dental tools like drills, marketing the benefits of minimally invasive procedures, reduced patient discomfort, and faster healing times. BIOLASE sold its products both in the United States and international markets through direct sales and distribution partnerships.

Current Company Status

BIOLASE, Inc. and its direct domestic subsidiaries initiated voluntary Chapter 11 bankruptcy proceedings. The company ceased business operations and no longer maintains assets. The BIOLQ ticker on OTC markets reflects this defunct status, and shares should be considered worthless or at extreme risk. Investors and researchers should treat any trading activity in BIOLQ with appropriate caution, as the company is no longer a going concern.

Historical Significance

For historical context, BIOLASE represented an attempt to bring laser technology into mainstream dental practice. The company's Waterlase technology was notable for its ability to work on hard tissue like enamel and bone, not just soft tissue, which differentiated it from many competing dental laser products. However, challenges in achieving widespread adoption and financial difficulties ultimately led to the company's bankruptcy filing.